CXCL10 and neoplasm: Given the critical roles of CXCL10 in regulating immune responses through activating and recruiting leukocytes such as T cells, eosinophils, monocytes, and NK cells, several groups indicated that increasing CXCL10 production of tumor cells might facilitate CAR-T cell treatment efficiency in solid tumors [46, 47].